Ipamorelin 5mg

Quickstart Highlights

Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue by mimicking ghrelin at the GH secretagogue receptor[1][2]. Its key advantage is high specificity for GH release without triggering ACTH or cortisol elevation, making it one of the safer GH secretagogues with minimal off-target hormonal effects[1][3]. This educational protocol presents a once-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
Typical daily range: 100–250 mcg once daily (gradual titration recommended).
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
Storage: Lyophilized: 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within ~4 weeks.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3.0 mL = ~1.67 mg/mL)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	100 mcg	6 units (0.06 mL)
Weeks 3–4	150 mcg	9 units (0.09 mL)
Weeks 5–8	200 mcg	12 units (0.12 mL)
Weeks 9–12	250 mcg	15 units (0.15 mL)

Frequency: Inject once daily subcutaneously, ideally 30–60 minutes before bedtime on an empty stomach to synergize with natural nocturnal GH secretion[4][5]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Reference-derived details for Ipamorelin 5mg.

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake vigorously).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (Ipamorelin, 5 mg each):
Peptide Vials (Ipamorelin, 5 mg each):: 8 weeks ≈ 2 vials
Peptide Vials (Ipamorelin, 5 mg each):: 12 weeks ≈ 4 vials
Peptide Vials (Ipamorelin, 5 mg each):: 16 weeks ≈ 5 vials
Insulin Syringes (U-100):
Insulin Syringes (U-100):: Per week: 7 syringes (1/day)
Insulin Syringes (U-100):: 8 weeks: 56 syringes
Insulin Syringes (U-100):: 12 weeks: 84 syringes
Insulin Syringes (U-100):: 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 16 weeks (5 vials): 15 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Stimulate endogenous growth hormone release to support anabolic processes related to muscle growth, fat metabolism, and tissue repair[1][2]. Open source
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired), followed by a 2–4 week pause to resensitize receptors.
Dose Range: 100–250 mcg daily with gradual titration; 200 mcg is a common middle-of-the-road dose.
Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
Storage: Lyophilized refrigerated or frozen; reconstituted refrigerated; use within ~4 weeks.

Dosing Protocol

Suggested daily titration approach.

Start: 100 mcg daily; increase by ~50 mcg every 1–2 weeks as tolerated.
Target: 200–250 mcg daily by Weeks 5–12.
Frequency: Once per day (subcutaneous), ideally 30–60 minutes before bedtime.
Cycle Length: 8–12 weeks; optional extension to 16 weeks, followed by 2–4 week off-cycle.
Timing: Evening bedtime dosing preferred; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at 2–8 °C (35.6–46.4 °F) for short-term or −20 °C (−4 °F) for long-term storage in dry, dark conditions[10][11]. Open source
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~4 weeks with bacteriostatic water[12]. For longer storage, freeze aliquots at −20 °C (−4 °F) and avoid repeated freeze–thaw cycles[11]. Open source
Allow vials to reach room temperature before opening to reduce condensation uptake[10]. Open source

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container[8]. Open source
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[7][8]. Open source
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
Ipamorelin has a short half-life (~1.5–2.5 hours)[4]; consistent daily timing maximizes effects. Open source

How This Works

Ipamorelin binds to the growth hormone secretagogue receptor (GHSR-1a) and stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner[1][2]. Unlike earlier growth hormone releasing peptides, ipamorelin is highly selective and does not significantly stimulate ACTH, cortisol, or prolactin release at effective doses[1][3]. After subcutaneous injection, GH levels peak within approximately 40 minutes and return to baseline by 2–3 hours[4]. This short-acting pulsatile effect makes it suitable for once-daily administration to support physiological GH patterns. Animal studies have shown that even chronic daily exposure did not significantly desensitize GH release mechanisms[5], though cycling is recommended as a precautionary measure. Ipamorelin has also demonstrated pro-motility effects in the gastrointestinal tract via GHSR-1a receptors, with preclinical and clinical studies showing it can accelerate gastric emptying[6].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

Supports increases in lean body mass and improvements in recovery through GH-mediated anabolic processes[1][2]. Open source
Enhances fat metabolism and supports favorable body composition changes over time[1]. Open source
High selectivity for GH release with minimal impact on other hormones (ACTH, cortisol, prolactin)[1][3]. Open source
May support improved gastric motility and digestive function[6]. Open source
Generally well tolerated with a low incidence of side effects at typical doses[3]. Open source
Occasional mild injection-site reactions (redness, swelling) may occur; very rare reports of water retention or increased hunger.

Lifestyle Factors

Complementary strategies for best outcomes.

Pair with a balanced, protein-adequate diet to support muscle synthesis and recovery.
Combine resistance training and cardiovascular exercise to maximize anabolic and metabolic benefits.
Prioritize 7–9 hours of quality sleep nightly, as GH naturally peaks during deep sleep phases.
Manage stress levels, as chronic stress and elevated cortisol can blunt GH response.
Inject on an empty stomach (avoid food 2–3 hours before and 30–60 minutes after) to optimize GH release.

Injection Technique

General subcutaneous guidance from clinical best-practice resources[7][8][9].

Clean your hands and work on a clean surface.
Swab the vial’s rubber stopper and injection site with alcohol; allow to dry.
Draw the calculated dose into the insulin syringe, eliminating air bubbles.
Suitable SC injection areas include the abdomen (2 inches from navel), outer thighs, upper outer arms, or flank/hip area[7]. Open source
Pinch a fold of skin between thumb and forefinger; insert the needle at 45–90° into subcutaneous tissue[7][8]. Open source
Do not aspirate for subcutaneous injections; inject slowly and steadily[8]. Open source
After injection, release the pinched skin and withdraw the needle at the same angle.
Apply gentle pressure with a clean cotton or alcohol pad; do not rub vigorously.
Rotate sites systematically with each dose to prevent irritation or tissue damage[7][9]. Open source
Immediately dispose of the used syringe in a proper sharps container[8]. Open source

Recommended Source

We recommend Prime Lab Peptides for high-purity Ipamorelin (5 mg).

High-purity, third-party-tested lots with batch certificates of analysis (COAs).
Consistent, quality-controlled manufacturing and documentation.
Reliable fulfillment with proper cold-chain handling to maintain peptide integrity.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References